Literature DB >> 25865396

Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase.

Zheng Xu1, Lu Cai2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25865396      PMCID： PMC5288810          DOI： 10.1016/j.yjmcc.2015.04.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  25 in total

1.  Signal transduction mechanisms involved in cardiac preconditioning: role of Ras-GTPase, Ca2+/calmodulin-dependent protein kinase II and epidermal growth factor receptor.

Authors:  Ibrahim F Benter; Jasbir S Juggi; Islam Khan; Mariam H M Yousif; Halit Canatan; Saghir Akhtar
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.

Authors:  Dandan Liang; Peng Zhong; Jie Hu; Feng Lin; Yuanyuan Qian; Zheng Xu; Jingying Wang; Chunlai Zeng; Xiaokun Li; Guang Liang
Journal:  J Mol Cell Cardiol       Date:  2015-03-07       Impact factor: 5.000

3.  Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning.

Authors:  Grant Williams-Pritchard; Matthew Knight; Louise See Hoe; John P Headrick; Jason N Peart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-01       Impact factor: 4.733

4.  Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase.

Authors:  Ibrahim F Benter; Mariam H M Yousif; Andrew J Hollins; Sioned M Griffiths; Saghir Akhtar
Journal:  J Vasc Res       Date:  2005-05-23       Impact factor: 1.934

5.  EGFR signaling promotes TGFβ-dependent renal fibrosis.

Authors:  Jianchun Chen; Jian-Kang Chen; Kojiro Nagai; David Plieth; Mingqi Tan; Tang-Cheng Lee; David W Threadgill; Eric G Neilson; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

6.  Involvement of epidermal growth factor receptor-protein tyrosine kinase transactivation in endothelin-1-induced vascular contraction.

Authors:  Yoshifumi Kawanabe; Tomoh Masaki; Nobuo Hashimoto
Journal:  J Neurosurg       Date:  2004-06       Impact factor: 5.115

7.  Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL/6J mice.

Authors:  Cordelia J Barrick; Ming Yu; Hann-Hsiang Chao; David W Threadgill
Journal:  Toxicol Appl Pharmacol       Date:  2008-03-07       Impact factor: 4.219

8.  Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes.

Authors:  Saeed Akhtar; Turki Almubrad; Anthony J Bron; Mariam H M Yousif; Ibrahim F Benter; Saghir Akhtar
Journal:  Acta Ophthalmol       Date:  2009-11       Impact factor: 3.761

9.  Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.

Authors:  Saghir Akhtar; Mariam H M Yousif; Gursev S Dhaunsi; Fatma Sarkhouh; Bindu Chandrasekhar; Sreeja Attur; Ibrahim F Benter
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

10.  High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR.

Authors:  Liang Han; Qingyong Ma; Junhui Li; Han Liu; Wei Li; Guodong Ma; Qinhong Xu; Shuang Zhou; Erxi Wu
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240
View more
  1 in total

Review 1.  The Role of iRhom2 in Metabolic and Cardiovascular-Related Disorders.

Authors:  Ramasatyaveni Geesala; Priya D Issuree; Thorsten Maretzky
Journal:  Front Cardiovasc Med       Date:  2020-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.